Viking Therapeutics Inc (NAS:VKTX)
$ 62.3 0.48 (0.78%) Market Cap: 6.87 Bil Enterprise Value: 5.85 Bil PE Ratio: 0 PB Ratio: 7.35 GF Score: 38/100

Q4 2019 Viking Therapeutics Inc Earnings Call Transcript

Feb 26, 2020 / 09:30PM GMT
Release Date Price: $6.23 (-2.20%)
Operator

Good day, and welcome to the Viking Therapeutics Fourth Quarter 2019 and year-end conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Stephanie Diaz of Investor Relations. Please go ahead.

Stephanie Diaz
Vida Strategic Partners Inc. - President & CEO

Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Senior Vice President of Finance. Before we begin, I'd like to caution that comments made during this conference call today, February 26, 2020, and will contain forward-looking statements within the meaning of the Securities Act of 1933 concerning the current beliefs of the company, which involve a number of assumptions, risks and uncertainties. Actual results could differ from these statements and the company undertakes no obligation to revise or update any statement made today. I encourage you to review all of the company's filings with the Securities and Exchange Commission concerning these and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot